Soviets Urged to Shorten Life of State Secrets

BRUSSELS—In 1972 Victor Brailovsky, then a 37-year-old cyberneticist, and his 32-year-old wife Irma, a computer scientist, applied for a visa to leave the Soviet Union. Four years later Victor was granted permission to emigrate to Israel but Irma was not. The reason, according to Soviet authorities, was that “she had been able during her work to listen and hear something secret.” Fifteen years later the Brailovskys finally arrived in Israel. Last month, at a meeting here orga

Written byEdward Carr
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BRUSSELS—In 1972 Victor Brailovsky, then a 37-year-old cyberneticist, and his 32-year-old wife Irma, a computer scientist, applied for a visa to leave the Soviet Union. Four years later Victor was granted permission to emigrate to Israel but Irma was not.

The reason, according to Soviet authorities, was that “she had been able during her work to listen and hear something secret.”

Fifteen years later the Brailovskys finally arrived in Israel. Last month, at a meeting here organized by the International Federation of Scientists for Soviet Refuseniks, they met with Western scientists to discuss when and for how long a government is justified in restricting the movement of scientists who possess secret knowledge. Despite Soviet leader Mikhail Gorbachev’s reforming spirit of glasnost, the Brailovskys said, the secrets that many scientists hold threaten to keep them in the Soviet Union forever.

Participants at the meeting focused on the question: How long does ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies